Percutaneous coronary intervention in a case of afibrinogenemia

Homa Falsoleiman1, Mehdi Hasanzadeh Daloee, Mashalla Dehghani

  • 1Mashhad Cardiac Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Insights

Congenital afibrinogenemia, a rare blood disorder, poses unique challenges in managing acute myocardial infarction. Successful percutaneous coronary intervention with a bare metal stent was achieved in a patient with this condition.

Area of Science:

  • Cardiology
  • Hematology
  • Genetics

Background:

  • Congenital afibrinogenemia is a rare autosomal recessive disorder characterized by a complete absence of fibrinogen.
  • Patients with congenital afibrinogenemia have a bleeding diathesis, making thrombotic events rare but management complex.

Observation:

  • A 30-year-old female with known congenital afibrinogenemia presented with acute anterior myocardial infarction.
  • Initial medical management with dual antiplatelet therapy and atorvastatin was insufficient to relieve her chest pain.

Findings:

  • The patient underwent successful percutaneous coronary intervention (PCI) of a proximal left anterior descending artery occlusion.
  • A bare metal stent was deployed, leading to complete resolution of ischemic symptoms.

Implications:

  • This case highlights the feasibility of successful PCI in patients with congenital afibrinogenemia.
  • Careful consideration of antiplatelet strategies and stent selection is crucial for managing thrombotic events in afibrinogenemia patients.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482